Search
Absci Corp
ABSIAdd to Watchlist
7.410USD
+0.230+3.20%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.16BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Absci Corp is 8.36, ranking 134 out of 389 in the Biotechnology & Medical Research industry. The average price target is 9.00, with a high of 10.00 and a low of 5.80.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
9.900
Target Price
+37.88%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Absci Corp
ABSI
11
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Absci Corp's expected revenue for the next quarter?
Absci Corp's expected revenue is 1.24M.
What is Absci Corp's price target?
Analysts forecast that Absci Corp's price target is USD 9.00, with the highest forecast at USD 10.00 and the lowest forecast at USD 5.80.
How have Absci CorpABSI's recent earnings per share performed?
The market expectation was USD -0.19, while Absci CorpABSI's earnings per share (EPS) for the previous quarter was USD -0.20. EPS for the next quarter is expected at USD -0.20.
What is the analyst rating for Absci Corp?
Based on the ratings of Absci Corp's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
